Welcome to our dedicated page for CoreCivic SEC filings (Ticker: CXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CoreCivic's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CoreCivic's regulatory disclosures and financial reporting.
CoreCivic reported a strong first quarter of 2026, boosted by facility activations and higher federal and state populations. Total revenue rose to $614.7 million, up 25.8% from a year earlier. Net income increased to $37.9 million, or $0.38 per diluted share, with Adjusted Diluted EPS at $0.40.
Profitability improved, with Adjusted EBITDA reaching $110.1 million, up 36.0%, and Normalized FFO per diluted share rising to $0.65. The company repurchased 2.3 million shares for $44.7 million, and leverage stood at 2.8x net debt to Adjusted EBITDA.
CoreCivic completed a roughly $148.0 million acquisition of Clinical Solutions Pharmacy, expects it to add $0.03–$0.05 per share in 2026, and raised full-year 2026 guidance for net income, EPS, FFO and Adjusted EBITDA. Updated guidance incorporates the CSP acquisition and the Midwest Regional Reception Center activation, while acknowledging a recent decrease in nationwide ICE populations.
CoreCivic, Inc. Amendment No. 3 to a Schedule 13G/A: River Road Asset Management, LLC reports beneficial ownership of 9,011,396 shares of Common Stock, representing 9.1% of the class. The filer reports sole voting power for 7,758,282 shares and sole dispositive power for 9,011,396 shares. The filing is signed on 05/05/2026 and shows a date of 03/31/2026 on the cover.
CoreCivic, Inc. Chief Administrative Officer Cole G. Carter executed an open-market sale of 12,500 shares of common stock at $20.64 per share. The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan, and Carter continues to directly hold 228,383 shares after the sale.
CXW submitted a Rule 144 notice reporting proposed and completed transactions in Common Stock. The filing records an RSU vesting event of 73,348 shares on 03/06/2025 and two reported dispositions by Cole G Carter: 12,500 shares sold on 03/02/2026 for $219,750.00 and 12,500 shares sold on 04/01/2026 for $236,212.00. Other header figures shown include 12500, $254,875.00, and 98,890,000 with an as of date 05/01/2026.
CoreCivic Inc reported that Vanguard Capital Management beneficially owns 5,002,380 shares of Common Stock, representing 5.11% of the class. The filing states Vanguard has sole dispositive power over 5,002,380 shares and sole voting power for 750,286 shares. The filing notes these holdings include positions held for Vanguard funds and certain affiliated investment vehicles.
CoreCivic Inc reported that Vanguard Portfolio Management beneficially owns 6,999,033 shares of Common Stock, representing 7.16% of the class. The filing shows Vanguard has sole dispositive power over 6,999,033 shares and sole voting power for 47,427 shares.
The disclosure is filed on behalf of Vanguard Portfolio Management and affiliated Vanguard entities and is signed by Ashley Grim, Head of Global Fund Administration.
CoreCivic, Inc. entered into a Second Amendment to its Fourth Amended and Restated Credit Agreement, adding a new $100 million Incremental Term Loan to its existing credit facility. The company plans to use this borrowing to pay down part of its revolving credit facility and for working capital and general corporate purposes.
Following the amendment, the total Amended Credit Facility is $800 million, consisting of a $125 million initial term loan, the new $100 million Incremental Term Loan, and a $575 million revolving credit facility with sublimits for swingline loans and standby letters of credit. The Incremental Term Loan matures 364 days after the amendment date and carries an interest margin 25 basis points higher than the margin on the initial term loan and revolver, which varies with CoreCivic’s consolidated total leverage ratio.
CoreCivic, Inc. Chief Administrative Officer Cole G. Carter sold 12,500 shares of Common Stock in an open-market transaction. The shares were sold at an average price of $18.94 each. After this sale, Carter directly holds 240,883 shares of CoreCivic common stock. The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted by Carter, indicating it was scheduled in advance rather than timed discretionarily.
Cole G Carter reported a sale of Common Stock under Rule 144. The filing shows a reported disposition of 12,500 shares on 03/02/2026 for $219,750.00. The excerpt also lists an RSU vesting event of 73,348 shares dated 03/06/2025.